| Members |
targetComponentId |
| Rivastigmine 9.5mg/24 hours transdermal patch (product) |
Rivastigmine 396 microgram/hour prolonged-release transdermal patch |
| Rivermead activities of daily living index (assessment scale) |
Rivermead Activities of Daily Living Scale (assessment scale) |
| Rizatriptan 10mg conventional release oral lyophilisate |
Rizatriptan only product in oral dose form |
| Rizatriptan 10mg wafer (product) |
Rizatriptan only product in oral dose form |
| Ro phenotype |
cDe haplotype (finding) |
| Robinow-like syndrome (disorder) |
Peters plus syndrome |
| Rochalimea henselae (organism) |
Bartonella henselae |
| Rochalimaea quintana |
Bartonella quintana |
| Rochalimea vinsonii (organism) |
Bartonella vinsonii |
| Rochalimea, NOS (organism) |
Bartonella |
| Rod monochromatism |
Complete achromatopsia |
| Romidepsin 10mg injection solution (product) |
Romidepsin 10 mg powder for solution for injection vial |
| Ropinirole 3mg extended release tablet (product) |
Ropinirole only product |
| Ropinirole hydrochloride 3mg tablet (product) |
Product containing precisely ropinirole (as ropinirole hydrochloride) 3 milligram/1 each conventional release oral tablet (clinical drug) |
| Ropinirole hydrochloride 500micrograms tablet (product) |
Ropinirole (as ropinirole hydrochloride) 500 microgram oral tablet |
| Ropivacaine hydrochloride 2mg/mL infusion solution 100mL bag (product) |
Product containing precisely ropivacaine hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Ropivacaine hydrochloride 2mg/mL infusion solution 200mL bag (product) |
Product containing precisely ropivacaine hydrochloride 2 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Ropivacaine hydrochloride 5mg/mL injection solution ampule (product) |
Product containing only ropivacaine in parenteral dose form (medicinal product form) |
| Rosacea (disorder) |
Rosacea (disorder) |
| Rose bengal 1% conventional release eye drops (product) |
Rose bengal only product |
| Rose bengal 1% single-use eye drops (product) |
Rose bengal only product |
| Rose bengal 1.3mg strip (product) |
Rose bengal only product |
| Roseola virus |
Human herpesvirus 6 |
| Rosiglitazone + rosiglitazone maleate 8mg/ns tablet (product) |
Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet |
| Rosiglitazone maleate 2mg tablet (product) |
Product containing precisely rosiglitazone (as rosiglitazone maleate) 2 milligram/1 each conventional release oral tablet (clinical drug) |
| Ross river fever |
Disease caused by Ross River virus (disorder) |
| Rotation flap graft of skin |
Reconstruction using local skin rotation flap (procedure) |
| Rotavirus infection of children |
Viral gastroenteritis due to Rotavirus |
| Round cell liposarcoma (disorder) |
Myxoid liposarcoma (disorder) |
| Round cell liposarcoma |
Myxoid liposarcoma |
| Royal Canadian Mounted Police health number |
Royal Canadian Mounted Police health number (observable entity) |
| Rubber in nose causing respiratory obstruction (event) |
Obstruction of respiratory tract caused by eraser in nose (disorder) |
| Rubeola virus antibody |
Measles virus antibody |
| Ruminococcus hansenii |
Blautia hansenii (organism) |
| Ruminococcus pasteurii |
Trichococcus pasteurii (organism) |
| Ruminococcus productus |
Blautia producta |
| Rupture of other tendons of foot and ankle, NEC (disorder) |
Rupture of tendon of foot and ankle |
| Rupture wrist flexors |
Rupture of flexor tendon of wrist (disorder) |
| Rusch 10mL balloon 12Ch DT71002 2-way PTFE coated male length urethral Foley catheter (physical object) |
Urinary catheter |
| Rusch 10mL balloon 18Ch DT71002 2-way PTFE coated male length urethral Foley catheter (physical object) |
Urinary catheter |
| Rusch 30mL balloon 16Ch DT73002 2-way PTFE coated male length urethral Foley catheter (physical object) |
Urethral catheter |
| Rusch 30mL balloon 18Ch DT73002 2-way PTFE coated male length urethral Foley catheter (physical object) |
Urinary catheter |
| Rusch 30mL balloon 18Ch DT83002 2-way PTFE coated female length urethral Foley catheter (physical object) |
Urinary catheter |
| Rusch 30mL balloon 20Ch DT73002 2-way PTFE coated male length urethral Foley catheter (physical object) |
Urinary catheter |
| Rusch 30mL balloon 22Ch DT73002 2-way PTFE coated male length urethral Foley catheter (physical object) |
Urinary catheter |
| Rusch 30mL balloon 22Ch DT83002 2-way PTFE coated female length urethral Foley catheter (physical object) |
Urinary catheter |
| Rusch 30mL balloon 24Ch DT73002 2-way PTFE coated male length urethral Foley catheter (physical object) |
Urinary catheter |
| Rusch 30mL balloon 26Ch DT73002 2-way PTFE coated male length urethral Foley catheter (physical object) |
Urinary catheter |
| Russian federation - Asia |
Russian Federation |
| Russian federation - Europe |
Russian Federation |
| Rz phenotype |
CDE haplotype (finding) |
| Réalisation d'un frottis cervical |
Sampling of cervix for Papanicolaou smear done (situation) |
| SH-antigen (hepatitis B) test |
Hepatitis B surface antigen measurement (procedure) |
| SNOMED RT Concept |
SNOMED CT Concept |
| Saccharothrix coeruleoviolacea |
Goodfellowia coeruleoviolacea |
| Saccharothrix flava |
Lechevalieria flava |
| Sacral dimples |
fossette sacro-coccygienne |
| Saddle-shaped |
Saddle shape |
| Saffron - dietary (substance) |
Saffron (substance) |
| Salbutamol 100mg/20mL nebulizer solution (product) |
Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
| Salbutamol 2.5mg/2.5mL nebulization unit (product) |
Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
| Salbutamol 200micrograms breath-actuated dry powder inhaler (product) |
Product containing precisely salbutamol (as salbutamol sulfate) 200 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
| Salbutamol 200micrograms inhalation capsule (product) |
Product containing precisely salbutamol (as salbutamol sulfate) 200 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
| Salbutamol 400micrograms inhalation capsule (product) |
Albuterol 400 microgram/actuation powder for inhalation |
| Salbutamol 5mg/2.5mL nebulization unit (product) |
Product containing precisely salbutamol (as salbutamol sulfate) 2 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
| Salbutamol+ipratropium bromide 2.5mg/500micrograms nebulization unit (product) |
Product containing precisely salbutamol (as salbutamol sulfate) 2.5 milligram/1 actuation conventional release solution for inhalation (clinical drug) |
| Salcatonin 200iu nasal spray (product) |
Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) |
| Salcatonin 200iu nasal spray (product) |
Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) |
| Salicoazosulfapyridine |
Product containing sulfasalazine (medicinal product) |
| Salicylamide |
Salicylamide |
| Salicylate extract (product) |
Product containing salicylate (product) |
| Salicylic acid 17% liquid (procedure) |
Salicylic acid 170 mg/mL cutaneous solution |
| Salicylic acid 17% liquid (product) |
Salicylic acid 170 mg/mL cutaneous solution |
| Salicylic acid 17% liquid+pack (product) |
Salicylic acid 170 mg/mL cutaneous solution |
| Salicylic acid 20% 7.5cmx4.5cm plaster (product) |
Product containing only salicylic acid in cutaneous dose form (medicinal product form) |
| Salicylic acid 20% 7.5cmx4.5cm plaster (product) |
Product containing only salicylic acid in cutaneous dose form (medicinal product form) |
| Salicylic acid 40% 7.5cmx4.5cm plaster (product) |
Product containing only salicylic acid in cutaneous dose form (medicinal product form) |
| Salicylic acid 40% 7.5cmx4.5cm plaster (product) |
Product containing only salicylic acid in cutaneous dose form (medicinal product form) |
| Salicylic acid+anthraquinone glycosides 1%/0.5% oral paint (product) |
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution |
| Salicylic acid+boric acid 3%/5% conventional release cutaneous powder (product) |
Product containing only boric acid and salicylic acid in cutaneous dose form (medicinal product form) |
| Salicylic acid+boric acid in purified talc 3%/5% powder (product) |
Product containing only boric acid and salicylic acid in cutaneous dose form (medicinal product form) |
| Salicylic acid+lactic acid 16.7%/16.7% paint (product) |
Lactic acid (as ammonium lactate) 167 mg/mL and salicylic acid 167 mg/mL cutaneous solution |
| Salinococcus hispanicus |
Salinicoccus hispanicus |
| Salinococcus roseus |
Salinicoccus roseus (organism) |
| Salinococcus species |
Genus Salinicoccus |
| Salivary dysfunction caries secondary to salivary gland disease |
Salivary dysfunction dental caries |
| Salivary stone |
calcul salivaire (trouble) |
| Salmeterol xinafoate 21mcg aerosol (product) |
Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug) |
| Salmeterol xinafoate 21mcg/spr aerosol (product) |
Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug) |
| Salmeterol xinafoate 21mcg/spray aerosol (product) |
Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug) |
| Salmeterol xinafoate 38.06mcg inhalant (product) |
Product containing precisely salmeterol (as salmeterol xinafoate) 21 microgram/1 actuation conventional release solution for inhalation (clinical drug) |
| Salmeterol xinafoate 50mcg powder (product) |
Salmeterol only product in pulmonary dose form |
| Salmeterol+fluticasone propionate 25micrograms/125micrograms inhaler |
Fluticasone and salmeterol only product in pulmonary dose form |
| Salmeterol+fluticasone propionate 25micrograms/250micrograms inhaler (product) |
Fluticasone and salmeterol only product in pulmonary dose form |
| Salmeterol+fluticasone propionate 25micrograms/50micrograms inhaler |
Fluticasone and salmeterol only product in pulmonary dose form |
| Salmon - dietary |
Salmon (substance) |
| Salmonella 1,4,12,27:b:[e,n,x} |
Salmonella II 1,4,12,27:b:[e,n,x] (organism) |
| Salmonella 16:b:e,n,x |
Salmonella Hvittingfoss (organism) |
| Salmonella 17:m,t:-- |
Salmonella Bama |
| Salmonella 3,10:b:e,n,x |
Salmonella Benfica (organism) |
| Salmonella 3,10:d:e,n,x |
Salmonella Souza (organism) |
FHIR